Achieve Life Sciences (ACHV) Change in Cash (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Change in Cash data on file, last reported at $7.4 million in Q1 2026.

• Quarterly Change in Cash rose 2700.0% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 million (up 128.62% YoY) and the FY2025 annual result came in at $8.2 million, up 389.62% from the prior year.
• Change in Cash improved to $7.4 million in Q1 2026, from -$11.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $50.8 million in Q1 2024 to a low of -$51.6 million in Q2 2024.
• A 5-year average of -$868176.5 and a median of -$5.2 million in 2023 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2024 — Change in Cash plunged 703.51% — and 2026, when it soared 2700.0%.
• Tracing ACHV's Change in Cash over 5 years: stood at $6.6 million in 2022, then slumped by 166.52% to -$4.4 million in 2023, then jumped by 173.38% to $3.2 million in 2024, then plunged by 442.82% to -$11.0 million in 2025, then surged by 166.94% to $7.4 million in 2026.
• The last three Change in Cash figures came in at $7.4 million (Q1 2026), -$11.0 million (Q4 2025), and -$19.9 million (Q3 2025), per Business Quant data.